I just watched a segment on Fox Business regarding the cannabis industry. The CEO of Canopy Growth said he has two medical trials in progress --- one for sleep disorders and another for anxiety. He said in the next year or two he hopes to have 60 medical trials underway. Canopy Growth stock is down on lower sales today. May I suggest that we are far ahead of them when it comes to medical trials? We also have had an outstanding peer review and we have the interest of several big pharma corporations. Good Times are soon to follow.


Kgem